Indegene recently launched TrialPedia 2.0 with Advantage Insights. It is an enhanced clinical trial analysis and decision support platform that hosts a real-time repository of clinical trial information with advanced search, data mining, and specialised service bureau services including custom research, analytics and reporting.
TrailPedia 2.0 will help clinical development and operations, R&D, Competitive Intelligence (CI), BD & Licensing as well as strategic marketing professionals effectively analyse clinical literature and trial data seamlessly, and benchmark competitive Clinical Development Programmes (CDPs)
across the industry. TrialPedia 2.0 has been designed to fulfill an unmet need in the industry to provide quick and comprehensive answers to strategic clinical development and marketing questions around market evolution, competitive label claims, licensing options and future sales projections. TrialPedia is the product of over 300 man-years of effort in assimilating knowledge to build a comprehensive analysis and benchmarking solution. The value of clinical trial analytics within TrialPedia 2.0 can be significantly enhanced via Advantage Insights, for clients looking for a comprehensive clinical trial reporting, analytics and benchmarking service.
Manish Gupta, CEO, Indegene said, “With TrialPedia Advantage Insights, in addition to clients gaining access to this best-in-class platform, they can leverage our deep research and analytics expertise for all their reporting and analysis needs. We believe that the Advantage Insights service bureau will help clients realise the true value of clinical trial analytics and help them navigate the business environment more effectively.”
EP News Bureau